NEW YORK— The federal government says health care facilities should stop using Hospira's Symbiq medication infusion pump because of its vulnerability to hacking. The FDA says the computerized pumps could be accessed remotely through a hospital's network, but it doesn't know of any cases where that has happened. Earlier this year the FDA and the Homeland...» Read More
The health-care industry is looking to harness big data, but finding the right workers isn't always easy. In some cases, companies are making acquisitions to bring talent in-house.
A team of oncologists from Sloan-Kettering have been working with IBM's Watson programmers and engineers to train the system to understand cancer treatment in the hopes of providing better care.
John Sculley, Former Apple CEO, Former PepsiCo President, and Partner at Sculley Brothers says Apple is still a strong player in the tech arena. He also sheds light on what could be the next big innovation from the technology and healthcare space.
Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.
The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.
In recent years, as the surgical robot's popularity has grown, so have questions and concerns about its safety, training and the aggressiveness of its marketing.
Irish drugmaker Elan has sweetened the terms on offer to shareholders under its $3.25 billion disposal plan, as it aims to stave off an approach for the company from U.S. investment firm Royalty Pharma.
A sharp and surprisingly persistent slowdown in the growth of health care costs is helping to narrow the federal deficit, leaving budget experts trying to figure out whether the trend will last.
Pfizer's unit Zoetis plans to sell 86.1 million shares at between $22 and $25 each in an initial public offering.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
States are setting up health insurance exchanges, reports CNBC's Bertha Coombs. Max Nisen, Business Insider, also weighs in.
It's hard to see how lawmakers can avoid touching health insurance if they want to eliminate loopholes and curtail deductions so as to raise revenue and lower tax rates.
DaVita could be a beneficiary among health care stocks from changes in the U.S. health care market, an analyst said Wednesday.
While Silicon Valley and other traditional high-tech hubs claim dominance as places for startups, demand for health care and other business services has put places like Indianapolis and Salt Lake City on the entrepreneurial map.
The managing partner of Google's venture capital, Bill Maris, says under-investment in health sciences is short-sighted.
The goal is to enable physicians and pharmaceutical companies to use complex genetic data to tailor treatment on an individual basis, according to Mike Pellini, CEO of Foundation Medical.
That may sound strange, but in a world where robots are becoming more common on assembly lines, in manufacturing plants and shipping centers, Baxter takes robotics to a new level.
Industries across the board are embracing the idea of collecting and analyzing data to predict future outcomes as a way to enhance product quality and gain a competitive edge.
Qualcomm's CEO Paul Jacobs says the smart phone will become a focal point for wirelessly connecting medical devices, diagnostics and sensors, and providing near real-time information.
The aging of America is taking a toll on the health care system. By 2050, the cost of treating Alzheimer's patients will hit $1 trillion a year.